 Fabienne Gally
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 7 | 2026 | 79 | 3.100 |
Why?
| | Macrophages, Alveolar | 4 | 2026 | 368 | 1.300 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 4 | 2026 | 923 | 1.090 |
Why?
| | Smoke | 4 | 2026 | 148 | 1.090 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 75 | 1.050 |
Why?
| | Neoplasm Proteins | 3 | 2026 | 444 | 0.970 |
Why?
| | PPAR gamma | 3 | 2022 | 177 | 0.850 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 55 | 0.830 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 53 | 0.770 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2026 | 2147 | 0.700 |
Why?
| | Inflammation | 7 | 2026 | 2880 | 0.700 |
Why?
| | Listeriosis | 2 | 2019 | 65 | 0.690 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 116 | 0.660 |
Why?
| | Immunity, Innate | 6 | 2017 | 846 | 0.660 |
Why?
| | Mucin-5B | 2 | 2022 | 234 | 0.590 |
Why?
| | Radiodermatitis | 1 | 2018 | 11 | 0.580 |
Why?
| | Macrophages | 3 | 2022 | 1511 | 0.540 |
Why?
| | Glycoproteins | 3 | 2021 | 355 | 0.510 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 691 | 0.500 |
Why?
| | Mice, Knockout | 8 | 2026 | 3125 | 0.500 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 153 | 0.500 |
Why?
| | Cytokines | 4 | 2019 | 2065 | 0.480 |
Why?
| | Lung | 9 | 2025 | 4109 | 0.410 |
Why?
| | Pneumonia | 3 | 2021 | 631 | 0.410 |
Why?
| | Mice | 19 | 2026 | 18365 | 0.400 |
Why?
| | Sphingomyelin Phosphodiesterase | 2 | 2025 | 27 | 0.390 |
Why?
| | Enhancer Elements, Genetic | 3 | 2025 | 192 | 0.380 |
Why?
| | Epithelial Cells | 4 | 2026 | 1126 | 0.370 |
Why?
| | Phosphoproteins | 2 | 2011 | 346 | 0.350 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 157 | 0.350 |
Why?
| | Lipopolysaccharides | 4 | 2025 | 863 | 0.340 |
Why?
| | Bronchi | 1 | 2013 | 267 | 0.330 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 356 | 0.330 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 221 | 0.330 |
Why?
| | Down-Regulation | 1 | 2013 | 627 | 0.320 |
Why?
| | Down Syndrome | 1 | 2017 | 534 | 0.320 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5997 | 0.290 |
Why?
| | Animals | 20 | 2026 | 38109 | 0.290 |
Why?
| | Acute Lung Injury | 2 | 2025 | 303 | 0.290 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 43 | 0.290 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 65 | 0.280 |
Why?
| | Influenza, Human | 1 | 2013 | 617 | 0.250 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 126 | 0.250 |
Why?
| | Cells, Cultured | 7 | 2019 | 4155 | 0.240 |
Why?
| | Asthma | 3 | 2026 | 1768 | 0.240 |
Why?
| | Oxidative Stress | 1 | 2013 | 1339 | 0.240 |
Why?
| | Bacterial Load | 2 | 2019 | 67 | 0.240 |
Why?
| | Haemophilus Infections | 1 | 2026 | 45 | 0.240 |
Why?
| | Wood | 1 | 2026 | 21 | 0.230 |
Why?
| | Haemophilus influenzae | 1 | 2026 | 67 | 0.230 |
Why?
| | Binding Sites | 2 | 2021 | 1331 | 0.230 |
Why?
| | Allergens | 1 | 2008 | 384 | 0.230 |
Why?
| | Gene Expression Regulation | 4 | 2025 | 2609 | 0.220 |
Why?
| | RNA, Messenger | 3 | 2019 | 2832 | 0.210 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1500 | 0.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 25 | 0.200 |
Why?
| | Cell Line | 2 | 2021 | 2882 | 0.200 |
Why?
| | Transcription Factors | 1 | 2011 | 1742 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 5 | 2026 | 2365 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2026 | 460 | 0.190 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 301 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 2 | 2025 | 138 | 0.190 |
Why?
| | Lung Injury | 1 | 2025 | 237 | 0.180 |
Why?
| | Humans | 20 | 2026 | 144957 | 0.180 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.170 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.170 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.170 |
Why?
| | NF-kappa B | 3 | 2019 | 662 | 0.170 |
Why?
| | RNA | 2 | 2025 | 940 | 0.170 |
Why?
| | A549 Cells | 1 | 2021 | 75 | 0.170 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.160 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 275 | 0.160 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 451 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 983 | 0.160 |
Why?
| | Th2 Cells | 2 | 2012 | 171 | 0.150 |
Why?
| | Blotting, Western | 2 | 2013 | 1187 | 0.150 |
Why?
| | Chromatin | 2 | 2021 | 561 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2026 | 1167 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 573 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 207 | 0.150 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 322 | 0.140 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 140 | 0.140 |
Why?
| | Alpha-Globulins | 1 | 2018 | 19 | 0.140 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1496 | 0.140 |
Why?
| | Models, Genetic | 1 | 2021 | 536 | 0.140 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2185 | 0.130 |
Why?
| | RNA Polymerase II | 1 | 2021 | 351 | 0.130 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 43 | 0.130 |
Why?
| | Dexamethasone | 1 | 2019 | 372 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 139 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4569 | 0.130 |
Why?
| | Apoptosis | 1 | 2025 | 2430 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 381 | 0.120 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 208 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2019 | 509 | 0.120 |
Why?
| | Disease Progression | 1 | 2023 | 2852 | 0.120 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 685 | 0.120 |
Why?
| | Cell Survival | 1 | 2019 | 1098 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1217 | 0.110 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 621 | 0.110 |
Why?
| | Protein Binding | 2 | 2018 | 2276 | 0.100 |
Why?
| | Skin | 1 | 2018 | 758 | 0.100 |
Why?
| | Base Sequence | 1 | 2017 | 2191 | 0.100 |
Why?
| | Immunoprecipitation | 1 | 2013 | 151 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 200 | 0.100 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 160 | 0.090 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 243 | 0.090 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1258 | 0.090 |
Why?
| | Ovalbumin | 2 | 2012 | 190 | 0.090 |
Why?
| | Antioxidants | 2 | 2014 | 549 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 370 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.090 |
Why?
| | Metalloporphyrins | 1 | 2012 | 66 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 336 | 0.090 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 21 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2013 | 169 | 0.090 |
Why?
| | Tobacco Products | 1 | 2013 | 84 | 0.090 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 89 | 0.090 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 76 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2013 | 348 | 0.080 |
Why?
| | Risk Factors | 2 | 2023 | 10792 | 0.080 |
Why?
| | Cartilage, Articular | 1 | 2015 | 343 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 851 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 276 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2012 | 499 | 0.070 |
Why?
| | Chimera | 1 | 2008 | 61 | 0.070 |
Why?
| | Radiation Protection | 1 | 2008 | 41 | 0.070 |
Why?
| | Lead | 1 | 2008 | 70 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 392 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 294 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 306 | 0.060 |
Why?
| | Immunoglobulin E | 1 | 2008 | 315 | 0.060 |
Why?
| | Gene Expression | 2 | 2022 | 1490 | 0.060 |
Why?
| | Immunization | 1 | 2008 | 374 | 0.060 |
Why?
| | Male | 5 | 2025 | 72406 | 0.060 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 337 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2008 | 502 | 0.060 |
Why?
| | Sphingomyelins | 1 | 2025 | 22 | 0.060 |
Why?
| | Receptors, Drug | 1 | 2004 | 10 | 0.060 |
Why?
| | Interleukin-8 | 1 | 2026 | 271 | 0.050 |
Why?
| | Sphingolipids | 1 | 2025 | 83 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2025 | 60 | 0.050 |
Why?
| | Ceramides | 1 | 2025 | 116 | 0.050 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 44 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2008 | 893 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 118 | 0.050 |
Why?
| | Potassium Channels | 1 | 2004 | 145 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Endothelium | 1 | 2023 | 119 | 0.050 |
Why?
| | Signal Transduction | 2 | 2019 | 5233 | 0.050 |
Why?
| | Particulate Matter | 1 | 2026 | 347 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1253 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1980 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2023 | 102 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 210 | 0.040 |
Why?
| | Cell Communication | 1 | 2023 | 324 | 0.040 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 9 | 0.040 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 674 | 0.040 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.040 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.040 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.040 |
Why?
| | Air Pollution | 1 | 2025 | 327 | 0.040 |
Why?
| | Lectins | 1 | 2021 | 45 | 0.040 |
Why?
| | Cell Size | 1 | 2021 | 92 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 535 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 538 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 374 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 299 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 627 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 316 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 683 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 870 | 0.030 |
Why?
| | Female | 3 | 2025 | 78376 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1464 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1134 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 32 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5965 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 187 | 0.020 |
Why?
| | Arginine | 1 | 2014 | 262 | 0.020 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.020 |
Why?
| | Running | 1 | 2015 | 228 | 0.020 |
Why?
| | Osteoarthritis | 1 | 2015 | 196 | 0.020 |
Why?
| | Bone and Bones | 1 | 2015 | 315 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 612 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 636 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 824 | 0.020 |
Why?
| | Knee Joint | 1 | 2015 | 426 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1835 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 79 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1173 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 476 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7183 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 332 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 4 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2499 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 169 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 369 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 35928 | 0.010 |
Why?
| | Adult | 1 | 2025 | 40506 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1619 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|